JAN 28, 2019 12:38 PM PST

New CRISPR Enzyme is Ready for Use

WRITTEN BY: Carmen Leitch

Researchers developed a gene-editing tool called CRISPR by utilizing a system bacteria use to defend themselves from invaders. It involves an enzyme that can cut the genome, Cas9. But that’s not the only genome-cutting enzyme around. Researchers, including those that originally developed CRISPR, have been evaluating others that could be used in place of Cas9, for different purposes, or to make the cutting action more specific. Now a team led by Feng Zhang and colleagues at the Broad Institute of MIT and Harvard, and co-author Eugene Koonin of the National Institutes of Health have created a new tool for editing the genomes of eukaryotes.

Image credit: Pixabay

This new technique uses an enzyme that targets the genome in a very specific way, called Cas12b. The enzyme comes from a microbe called Bacillus hisashii, and its small size makes it especially useful in vivo. The team wants to make the enzyme widely available to other research groups, and have reported their work in Nature Communications. Their reagents can also be easily accessed at Addgene.

The Cas12b enzyme was first identified back in 2015, but because it loves extreme environments like volcanoes and hot springs, it is only active at very high temperatures, much hotter than the environment inside the human body. In its natural state it's not ready for clinical applications. But a modified form might be, the researchers thought.

"We searched for inspirations from nature," Zhang said. "We wanted to create a version of Cas12b that could operate at lower temperatures, so we scanned thousands of bacterial genetic sequences, looking in bacteria that could thrive in the lower temperatures of mammalian environments."

The researchers were able to assess potential candidates and engineer changes in the ones that stood out. They created a new version of Cas12b that can edit primary human T cells efficiently, opening up a new avenue to target the human immune system.

"This is further evidence that there are many useful CRISPR systems waiting to be discovered," noted the first author of the study Jonathan Strecker, a postdoc in the Zhang Lab and a Human Frontiers Science program fellow.

The Cas12b enzyme family has been under study since it was discovered. Other researchers including a team led by Jennifer Doudna, one of the CRISPR tool’s original inventors, has identified other useful Cas12b enzymes from different microbes.

Dr. Zhang is featured in the video above, giving a talk at the Keystone Symposia on Molecular and Cellular Biology. The video below discusses some of the differences between Cas9 and Cpf1, one type of Cas12 enzyme.


Sources: Phys.org via MIT, Nature Communications

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
NOV 21, 2019
Genetics & Genomics
NOV 21, 2019
We Already Have the Ingredients for the Next Food Revolution
The third agricultural revolution changed the way millions of people lived in the 1950s and 60s. It's now time for another one....
NOV 21, 2019
Genetics & Genomics
NOV 21, 2019
Mutants Are Everywhere - You're One Too
As fathers age, they tend ot pass down more genetic mutations to their children....
NOV 21, 2019
Genetics & Genomics
NOV 21, 2019
Hypersexual Disorder Caused by Faulty Genes
Hypersexual disorder is a condition in which people experience sexual fantasies and urges so intense that they disrupt their daily lives. Affecting be...
NOV 21, 2019
Drug Discovery & Development
NOV 21, 2019
Therapeutic Targets Inflammation Associated with Genetic Heart Disease
Often times when young athletes collapse during the game it is due to sudden cardiac death as a result of the inherited arrhythmogenic cardiomyopathy (ACM)...
NOV 21, 2019
Genetics & Genomics
NOV 21, 2019
Even Different Species of Butterflies Can Easily Share Genes
After assessing the genomes of twenty species of butterflies, scientists were surprised to find that genes flow easily between them....
NOV 21, 2019
Drug Discovery & Development
NOV 21, 2019
Gene Variant Could Be a Therapeutic Target For Alzheimer Disease
A variation in genetics for an individual at high-risk for Alzheimer development has defied the odds for being dementia-free way beyond anticipated. The in...
Loading Comments...